Despite the several immunosuppressants used, where the majority received corticosteroids and azathioprine to fewer patients receiving methotrexate, rituximab, etc., we only found differential levels of five proteins, CXCL10, TNFSF14, CCL11, IL-17C, and TGF-α, between MG patients with and without immunosuppressants. This evidence concerns the gene IL17C and myasthenia gravis.